Biohaven
NYSE: BHVNFounded 2022 · 3 known investors
Biohaven is a biopharmaceutical company developing treatments in immunology, obesity, neuroscience, and oncology, with approved migraine therapies and a pipeline of early-to-late-stage drug development programs.
BiotechHealthtech
Investors · 3
Competitors · 2
by search overlapBiogen Idec47 shared keywordsBiogen is a biotechnology company founded in 1978 that focuses on breakthroughs in biology. The company serves patients through research and development in the life sciences industry.
Seeking Alpha40 shared keywordsSeeking Alpha is a financial research platform that provides stock analysis, investment tools, and market coverage across asset classes to investors. The platform aggregates research from thousands of analysts and investors, offering ratings, articles, and investment ideas.
Companies competing with Biohaven for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Biohaven do?
- Biohaven is a biopharmaceutical company developing treatments in immunology, obesity, neuroscience, and oncology, with approved migraine therapies and a pipeline of early-to-late-stage drug development programs.
- Who are Biohaven's investors?
- Biohaven's investors include Oberland Capital, RA Capital, Sixth Street.